In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

QR Code

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

Abstract Effective and affordable treatments for patients suffering from coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), are needed. We report in vitro efficacy of Artemisia annua extracts as well as artemisinin, artesunate, and artemether...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Yuyong Zhou, Kerry Gilmore, Santseharay Ramirez, Eva Settels, Karen A. Gammeltoft, Long V. Pham, Ulrik Fahnøe, Shan Feng, Anna Offersgaard, Jakob Trimpert, Jens Bukh, Klaus Osterrieder, Judith M. Gottwein, Peter H. Seeberger
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2021
Sujets:	Medicine R Science Q
Accès en ligne:	https://doaj.org/article/cb60e70748c8410cbc59a6f8b48eb14d
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Productive homologous and non-homologous recombination of hepatitis C virus in cell culture.
par: Troels K H Scheel, et autres
Publié: (2013)

Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication.
par: Susan Obeid, et autres
Publié: (2013)

Nanoliposomal artemisinin for the treatment of murine visceral leishmaniasis
par: Want MY, et autres
Publié: (2017)

Aging affects artemisinin synthesis in Artemisia annua
par: Jiao Li, et autres
Publié: (2021)

Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria
par: Moses Ikegbunam, et autres
Publié: (2021)

Analysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.
par: Troels K H Scheel, et autres
Publié: (2012)

Nicotiana benthamiana as a production platform for artemisinin precursors.
par: Teun W J M van Herpen, et autres
Publié: (2010)

The apicoplast link to fever-survival and artemisinin-resistance in the malaria parasite
par: Min Zhang, et autres
Publié: (2021)

Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome
par: Jessica L. Bridgford, et autres
Publié: (2018)

Investigation of the Effects of Artemisinin on Testis and Kidney Injury Induced by Doxorubicin
par: Tutun Hidayet, et autres
Publié: (2019)

Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum
par: Afolabi Owoloye, et autres
Publié: (2021)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
par: Lei Zhu, et autres
Publié: (2018)

Protein abundance and folding rather than the redox state of Kelch13 determine the artemisinin susceptibility of Plasmodium falciparum
par: Robin Schumann, et autres
Publié: (2021)

Toxicological effect of Artemisinin-Based Combination Therapies plus Paracetamol in malaria patients
par: S.E. Aghahowa, et autres
Publié: (2021)

Genetic screens reveal a central role for heme metabolism in artemisinin susceptibility
par: Clare R. Harding, et autres
Publié: (2020)

Systematic review and meta-analysis of artemisinin based therapies for the treatment and prevention of schistosomiasis.
par: Luis Pérez del Villar, et autres
Publié: (2012)

Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
par: M. Isabel Veiga, et autres
Publié: (2016)

In Vitro Adventitious Regeneration of <i>Artemisia annua</i> L. Influencing Artemisinin Metabolism
par: Federica Blando, et autres
Publié: (2021)

Knockout of the peroxiredoxin 5 homologue PFAOP does not affect the artemisinin susceptibility of Plasmodium falciparum
par: Carine F. Djuika, et autres
Publié: (2017)

Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity.
par: Lucy C Okell, et autres
Publié: (2008)

Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar.
par: Achuyt Bhattarai, et autres
Publié: (2007)

Restructured Mitochondrial-Nuclear Interaction in Plasmodium falciparum Dormancy and Persister Survival after Artemisinin Exposure
par: Sean V. Connelly, et autres
Publié: (2021)

To what extent are the antimalarial markets in African countries ready for a transition to triple artemisinin-based combination therapies?
par: Freek de Haan, et autres
Publié: (2021)

Artemisinin-resistant K13 mutations rewire Plasmodium falciparum’s intra-erythrocytic metabolic program to enhance survival
par: Sachel Mok, et autres
Publié: (2021)

Histone acetyltransferase PfGCN5 regulates stress responsive and artemisinin resistance related genes in Plasmodium falciparum
par: Mukul Rawat, et autres
Publié: (2021)

Artemisinin Binds and Inhibits the Activity of <i>Plasmodium falciparum</i> Ddi1, a Retroviral Aspartyl Protease
par: Noah Machuki Onchieku, et autres
Publié: (2021)

Malaria burden and artemisinin resistance in the mobile and migrant population on the Thai-Myanmar border, 1999-2011: an observational study.
par: Verena I Carrara, et autres
Publié: (2013)

Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India
par: Sabyasachi Das, et autres
Publié: (2021)

Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
par: Deeptashree Nandi, et autres
Publié: (2021)

Finding the right balance: implementation of public–private partnership in artemisinin-based combination therapy provision in Manokwari, Indonesia
par: Astri Ferdiana, et autres
Publié: (2021)

High-level production of amorpha-4,11-diene, a precursor of the antimalarial agent artemisinin, in Escherichia coli.
par: Hiroko Tsuruta, et autres
Publié: (2009)

Assessing antimalarial efficacy in a time of change to artemisinin-based combination therapies: the role of Médecins Sans Frontières.
par: Jean-Paul Guthmann, et autres
Publié: (2008)

Protective Effect of Dietary Vitamin E (α Tocopherol) on Artemisinin Induced Oxidative Liver Tissue Damage in Rats
par: Zaki,Mohamed Samir Ahmed, et autres
Publié: (2020)

Deciphering the Role of Humoral and Cellular Immune Responses in Different COVID-19 Vaccines—A Comparison of Vaccine Candidate Genes in Roborovski Dwarf Hamsters
par: Jakob Trimpert, et autres
Publié: (2021)

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
par: Paul M. O’Neill, et autres
Publié: (2017)

Studies of Potency and Efficacy of an Optimized Artemisinin-Quinoline Hybrid against Multiple Stages of the <i>Plasmodium</i> Life Cycle
par: Helenita C. Quadros, et autres
Publié: (2021)

Scale-up of malaria rapid diagnostic tests and artemisinin-based combination therapy: challenges and perspectives in sub-Saharan Africa.
par: Guido J H Bastiaens, et autres
Publié: (2014)

Malaria case-management following change of policy to universal parasitological diagnosis and targeted artemisinin-based combination therapy in Kenya.
par: Andrew Nyandigisi, et autres
Publié: (2011)

Antigenic and immunogenic evaluation of permutations of soluble hepatitis C virus envelope protein E2 and E1 antigens.
par: Jannick Prentoe, et autres
Publié: (2021)

Elucidation of DNA Repair Function of PfBlm and Potentiation of Artemisinin Action by a Small-Molecule Inhibitor of RecQ Helicase
par: Niranjan Suthram, et autres
Publié: (2020)